Opioid Use Disorders - PubMed (original) (raw)
Review
Opioid Use Disorders
Bikash Sharma et al. Child Adolesc Psychiatr Clin N Am. 2016 Jul.
Abstract
Opioid use and addiction in adolescents and young adults is a health problem of epidemic proportions, with devastating consequences for youth and their families. Opioid overdose is a life-threatening emergency that should be treated with naloxone, and respiratory support if necessary. Overdose should always be an opportunity to initiate addiction treatment. Detoxification is often a necessary, but never sufficient, component of treatment for OUDs. Treatment for OUDs is effective but treatment capacity is alarmingly limited and under-developed. Emerging consensus supports the incorporation of relapse prevention medications such as buprenorphine and extended release naltrexone into comprehensive psychosocial treatment including counseling and family involvement.
Keywords: Heroin; Injection; Opioid use disorder; Opioids; Overdose; Prescription opioids; Withdrawal.
Copyright © 2016 Elsevier Inc. All rights reserved.
Figures
Figure 1. Past year initiation of heroin among individuals aged 12 or older, by age group: 2002 to 2013
From Lipari RN and Hughes A. The NSDUH Report: Trends in Heroin Use in the United States: 2002 to 2013. The CBHSQ Report: April 23, 2015. Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. Rockville, MD; with permission.
Similar articles
- Characteristics and Receipt of Medication Treatment Among Young Adults Who Experience a Nonfatal Opioid-Related Overdose.
Bagley SM, Larochelle MR, Xuan Z, Wang N, Patel A, Bernson D, Silverstein M, Hadland SE, Land T, Samet JH, Walley AY. Bagley SM, et al. Ann Emerg Med. 2020 Jan;75(1):29-38. doi: 10.1016/j.annemergmed.2019.07.030. Epub 2019 Oct 4. Ann Emerg Med. 2020. PMID: 31591014 Free PMC article. - Trends in pharmacy-based dispensing of buprenorphine, extended-release naltrexone, and naloxone during the COVID-19 pandemic by age and sex - United States, March 2019 - December 2020.
Cremer LJ, Board A, Guy GP Jr, Schieber L, Asher A, Parker EM. Cremer LJ, et al. Drug Alcohol Depend. 2022 Mar 1;232:109192. doi: 10.1016/j.drugalcdep.2021.109192. Epub 2021 Nov 26. Drug Alcohol Depend. 2022. PMID: 35065513 Free PMC article. - Prevention of Opioid Overdose.
Babu KM, Brent J, Juurlink DN. Babu KM, et al. N Engl J Med. 2019 Jun 6;380(23):2246-2255. doi: 10.1056/NEJMra1807054. N Engl J Med. 2019. PMID: 31167053 Review. No abstract available. - Buprenorphine and naloxone access in pharmacies within high overdose areas of Los Angeles during the COVID-19 pandemic.
Dadiomov D, Bolshakova M, Mikhaeilyan M, Trotzky-Sirr R. Dadiomov D, et al. Harm Reduct J. 2022 Jun 29;19(1):69. doi: 10.1186/s12954-022-00651-3. Harm Reduct J. 2022. PMID: 35768817 Free PMC article. - Current Best Practices for Acute and Chronic Management of Patients with Opioid Use Disorder.
Peterkin A, Laks J, Weinstein ZM. Peterkin A, et al. Med Clin North Am. 2022 Jan;106(1):61-80. doi: 10.1016/j.mcna.2021.08.009. Med Clin North Am. 2022. PMID: 34823735 Review.
Cited by
- An Indigenous-led buprenorphine-naloxone treatment program to address opioid use in remote Northern Canada.
Zuk AM, Ahmed F, Charania NA, Sutherland C, Kataquapit G, Moriarity RJ, Spence ND, Tsuji LJS, Liberda EN. Zuk AM, et al. Dialogues Health. 2024 Sep 1;5:100190. doi: 10.1016/j.dialog.2024.100190. eCollection 2024 Dec. Dialogues Health. 2024. PMID: 39296322 Free PMC article. - Emergency department management of opioid use disorder in pediatric patients.
Schwarz ES, Dietrich AM, Sandelich S, Hooley G, Rose E, Ruttan T, Simon EL, Sulton C, Wall J. Schwarz ES, et al. J Am Coll Emerg Physicians Open. 2024 Aug 25;5(5):e13265. doi: 10.1002/emp2.13265. eCollection 2024 Oct. J Am Coll Emerg Physicians Open. 2024. PMID: 39193084 Free PMC article. - Acute opioid overdose in pediatric patients.
Sandelich S, Hooley G, Hsu G, Rose E, Ruttan T, Schwarz ES, Simon E, Sulton C, Wall J, Dietrich AM. Sandelich S, et al. J Am Coll Emerg Physicians Open. 2024 Mar 7;5(2):e13134. doi: 10.1002/emp2.13134. eCollection 2024 Apr. J Am Coll Emerg Physicians Open. 2024. PMID: 38464332 Free PMC article. - Association of opioid or other substance use disorders with health care use among patients with suicidal symptoms.
Vekaria V, Patra BG, Xi W, Murphy SM, Avery J, Olfson M, Pathak J. Vekaria V, et al. J Subst Use Addict Treat. 2024 Jan;156:209177. doi: 10.1016/j.josat.2023.209177. Epub 2023 Oct 9. J Subst Use Addict Treat. 2024. PMID: 37820869 - MedSMA℞T Adventures in PharmaCity Game: Youth Experiences and Recommendation for Use in Opioid Safety Education.
Abraham O, Koeberl CR, McCarthy TJ. Abraham O, et al. Pharmacy (Basel). 2023 Sep 10;11(5):143. doi: 10.3390/pharmacy11050143. Pharmacy (Basel). 2023. PMID: 37736915 Free PMC article.
References
- Pradip, et al. Associations of Nonmedical Pain Reliever Use and Initiation of Heroin Use in the US. Center for behavioral Health Statistics and Quality Data Review. SAMHSA; 2013.
- Mills KL, Teesson M, Darke S, Ross J, et al. Young people with heroin dependence: Findings from the Australian Treatment Outcome Study (ATOS) Journal of Substance Abuse Treatment. 2004;27:67–73. - PubMed
- Uhl GR, Grow RW. The burden of complex genetics in brain disorders. Arch Gen Psychiatry. 2004 Mar;61(3):223–9. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical